Cms extracellular vesicles

Show results for

Unknown (23)
Genomics (8)
Transcriptomics (4)
Proteomics (4)
Metabolomics (1)

Organisms

Alphavirus (4)
Archaea (4)
Bacteria (4)
Betaherpesvirinae (4)
Borrelia (4)
Botrytis cinerea (4)
Chlorella vulgaris (4)
Clostridium perfringens (4)
Enterovirus A71 (4)
Eukaryota (4)
Fungi (4)
Hepatitis B virus (4)
Human alphaherpesvirus 1 (4)
Human betaherpesvirus 5 (4)
Influenza A virus (4)
Influenza C virus (4)
Japanese encephalitis virus group (4)
Listeria monocytogenes (4)
Mammarenavirus (4)
Miscanthus x giganteus (4)
Mycobacterium tuberculosis (4)
Orthoflavivirus (4)
Panicum virgatum (4)
Pseudomonas aeruginosa (4)
Rattus (4)
Severe acute respiratory syndrome coronavirus 2 (4)
Staphylococcus aureus (4)
Streptococcus pneumoniae (4)
Homo sapiens (3)
Rattus norvegicus (2)

Organisms

Homo sapiens (4)

Repository

ENA (7)
pride (4)
biostudies-arrayexpress (3)
geo (2)
MetaboLights (1)

Tissue

Blood serum (2)
Cardiac muscle cell (1)
Cell culture (1)
Fibroblast (1)
Leukocyte (1)
Muscle (1)
Thyroid cancer cell (1)
Thyroid gland (1)

Disease

Familial hypercholesterolemia (1)
Thyroid cancer (1)

Technology Type

Mass Spectrometry (4)
Bottom-up proteomics (2)
Data-dependent acquisition (2)
Mass spectrometry (1)
Data-independent acquisition (1)
Shotgun proteomics (1)
Top-down proteomics (1)

Instrument Platform

Illumina HiSeq 2500 (2)
Illumina NovaSeq 6000 (1)
Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2024 (4)
2025 (2)
2022 (2)
2021 (1)
2026 (1)

Metabolite Name

1-Fluoro-25-hydroxy-16-ene-23-yne-26,27-hexadeuterovitamin-D3 (1)
24,24-difluoro-1alpha,25-dihydroxy-24a-homocholecalciferol (1)
1alpha-hydroxy-22-oxacholecalciferol (1)
AC2SGL(18:0/36:0(2Me[S],4Me[S],6Me[S],8Me[S],10Me[S],12Me[R],14Me[R],16Me[R],18Me[R],19OH)) (1)
C25:3 Highly branched isoprenoid A (1)
Hoslundin (1)
Sophoracoumestan A (1)
PIM2(19:0/16:0) (1)
PA(P-16:0/20:5(5Z,8Z,11Z,14Z,17Z)) (1)
PI(22:2(13Z,16Z)/22:1(11Z)) (1)
PI(20:3(8Z,11Z,14Z)/22:2(13Z,16Z)) (1)
PI(17:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (1)
PG(15:0/22:4(7Z,10Z,13Z,16Z)) (1)
PE-Cer(d16:2(4E,6E)/20:1(11Z)(2OH)) (1)
Isoglobotriglycosylceramide(d18:1/26:0) (1)
PS(P-16:0/19:1(9Z)) (1)
PI(20:2(11Z,14Z)/22:1(11Z)) (1)
PA(P-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (1)
CL(1'-[16:0/16:0],3'-[16:0/16:0]) (1)
CL(1'-[16:0/16:0],3'-[18:1(9Z)/16:0]) (1)
Isoglobotriglycosylceramide(d18:1/24:0) (1)
PI(16:1(9Z)/22:1(11Z)) (1)
1,25-Dihydroxycholesterol (1)
CL(1'-[20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z)],3'-[20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)]) (1)
CL(1'-[16:0/18:0],3'-[18:0/20:0]) (1)
PI(22:4(7Z,10Z,13Z,16Z)/22:1(11Z)) (1)
Isoglobotriglycosylceramide(d18:1/22:0) (1)
Dodecaprenyl phosphate-galacturonic acid (1)
PA(20:4(5Z,8Z,11Z,14Z)/21:0) (1)
MfGL-II (1)

First Public Date

2024 (5)
2025 (1)
2022 (1)

Study type

RNA-seq of total RNA (1)
RNA-seq of coding RNA (1)
RNA-seq of non coding RNA (1)

Release Date

2024 (9)
2025 (6)
2020 (5)
2021 (2)
2026 (1)
2023 (1)
2022 (1)
2019 (1)

Lab affiliation

1.Semmelweis University, Department of Pharmacology and Pharmacotherapy, Budapest, Hungary. 2.Pharmahungary Group, Szeged, Hungary (1)
Proteomics Service CIC bioGUNE, Build. 800 Bizkaia Tech. Derio 48160 Spain (1)
Proteomics, Leibniz-Institut für Analytische Wissenschaften-ISAS-e.V., Dortmund, Germany (1)
Proteomics, Leibniz-Institut für analytische Wissenschaften -ISAS - e.V., Germany (1)

Tags

xref:PubMed:38451249 (1)

Previous page
1 / 4
You're on page 1
page 2
page 3
page 4
Next page

Sort by:

Relevance

Page size

The Impacts of Sortase A and the 4'-Phosphopantetheinyl Transferase Homolog Sfp on Streptococcus mutans Extracellular Membrane Vesicle Biogenesis

Extracellular membrane vesicles (EMVs) are produced by many Gram-positive organisms, but information regarding vesiculogenesis is incomplete. We used single gene deletions to evaluate the impacts on Streptococcus mutans EMV biogenesis of Sortase A (SrtA), which affects S. mutans...

2021-10-06 | MTBLS1812 | MetaboLights

Human iPSC-derived cardiomyocytes under hypoxia/normoxia, treated with bone marrow or cardiac stromal cell extracellular vesicles

RNA-seq was performed on cultured human induced pluripotent cell derived cardiomyocytes (iPSC-CMs). There are four groups, with three samples per group: H1,H2,H3. Negative control. Healthy, normoxic iPSC-CMs D1,D2,D3. Positive control. iPSCs cultured under hypoxic (0-1% O2) for 48h with 2% v/v PBS ...

ORGANISM(S): Homo sapiens

2024-10-02 | E-MTAB-13966 | biostudies-arrayexpress

Small RNA-Seq for primary rat hepatic stellate cells and hepatic stellate cell-derived small extracellular vesicles

Aims: To obtain small non-coding RNA expression profiles of short-term activated and long-term activated hepatic stellate cells (HSCs). To obtain small non-coding RNA expression profiles of small extracellular vesicles (sEVs) from short-term activated and long-term activated HSCs. Methods: Primar...

ORGANISM(S): Rattus norvegicus

2024-08-29 | E-MTAB-12764 | biostudies-arrayexpress

RNA-Seq for primary rat Kupffer cells and monocytes treated with hepatic stellate cell-derived small extracellular vesicles

Aim: To find out the effects of small extracellular vesicles (sEVs) from short-term activated and long-term activated hepatic stellate cells (HSCs) on Kupffer cells (KCs) and bone marrow-derived monocytes (MOs). Methods: For the isolation of HSC-derived sEVs, culture media (CMs) from Day 0 to Day 3 ...

ORGANISM(S): Rattus norvegicus

2024-08-29 | E-MTAB-12754 | biostudies-arrayexpress

Proteomics analysis of extracellular vesicles from thyroid tumours

Extracellular vesicles (EVs) participate in cell-stroma crosstalk within tumor microenvironment (TME) and Fb are key elements that contribute to tumor promotion. In thyroid cancer, the most prevalent endocrine malignancy, the relevance of Fb in the TME and EVs is beginning to be deciphered. Using an...

ORGANISM(S): Homo sapiens (Human)

2022-08-02 | PXD028081 | Pride